Kb Financial Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Kb Financial Partners, LLC
- $350 Million
- Q3 2023
A detailed history of Kb Financial Partners, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kb Financial Partners, LLC holds 3 shares of REGN stock, worth $1,810. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 3
-0.0%
Holding current value
$1,810
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,470Shares Held
88MCall Options Held
1.15MPut Options Held
1.39M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.68 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.1 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.42 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.92 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.41 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...